Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

  • Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

GW Pharmaceuticals PLC

+ Add to Watchlist


9.1500 USD 0.0500 0.55%

As of 20:10:04 ET on 05/04/2015.

Company Profile for GW Pharmaceuticals PLC (GWPRF)

GW Pharmaceuticals plc researches and develops cannabinoid prescription medicines for the treatment of cancer pain, Multiple Sclerosis, and neuropathic pain.

Contact Information

GW Pharmaceuticals PLC

Porton Down Science Park
Wiltshire, SP4 0JQ
United Kingdom
Phone: 44-19-8055-7000
Fax: 44-19-8055-7111

Key Executives for GW Pharmaceuticals PLC (GWPRF)

Geoffrey William GuyChairman/FounderJustin David GoverChief Executive Officer
Adam David GeorgeCFO/SecretaryChristopher John Tovey "Chris"Chief Operating Officer
Stephen D SchultzVP:Investor RelationsStephen WrightDirector:Research & Dev

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

sec ||= nil